Stockreport

Amylyx Pharmaceuticals Highlights Avexitide LUCIDITY Phase 3 Enrollment, Q3 Data Timing at Leerink Conf. [Yahoo! Finance]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF for avexitide has finished screening and expects top-line results in the third quarter, using Level II/III hypoglycemia endpoints with a run-in to confirm qualifying eve [Read more]